140 related articles for article (PubMed ID: 28077489)
1. Rescue of severe brain and cervical cord IRIS by restarting natalizumab in a pregnant MS patient.
Massey TH; Smith R; Sadiq S; Overton C; Pearson OR
Neurology; 2017 Feb; 88(7):711-713. PubMed ID: 28077489
[No Abstract] [Full Text] [Related]
2. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
[TBL] [Abstract][Full Text] [Related]
3. Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
Scarpazza C; Prosperini L; Mancinelli CR; De Rossi N; Lugaresi A; Capobianco M; Moiola L; Naldi P; Imberti L; Gerevini S; Capra R
J Neurol Sci; 2017 Jul; 378():233-237. PubMed ID: 28566170
[TBL] [Abstract][Full Text] [Related]
4. Natalizumab-associated cerebellar PML: a case report on how to slow down IRIS.
Lauda F; Fangerau T; Javaheripour-Otto K; Pinkhardt E; Kassubek J; Tumani H
J Neurol; 2015; 262(4):1055-7. PubMed ID: 25663412
[No Abstract] [Full Text] [Related]
5. [Immune reconstitution inflammatory syndrome and rebound syndrome in multiple sclerosis patients who stopped disease modification therapy: current understanding and a case report].
Belova AN; Rasteryaeva MV; Zhulina NI; Belova EM; Boyko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):74-84. PubMed ID: 28617365
[TBL] [Abstract][Full Text] [Related]
6. High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc.
Stork L; Brück W; Bar-Or A; Metz I
Acta Neuropathol; 2015 Mar; 129(3):467-8. PubMed ID: 25604548
[No Abstract] [Full Text] [Related]
7. Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
Calvi A; De Riz M; Pietroboni AM; Ghezzi L; Maltese V; Arighi A; Fumagalli GG; Jacini F; Donelli C; Comi G; Galimberti D; Scarpini E
Immunotherapy; 2014; 6(1):23-8. PubMed ID: 24341880
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Métivier D; Arnaud FX; Dutasta F; Nguema B; Teriitehau C; Berets O; Baccialone J; Potet J
Diagn Interv Imaging; 2013 Jan; 94(1):101-3. PubMed ID: 23228283
[No Abstract] [Full Text] [Related]
9. Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
Aguirre C; Meca-Lallana V; Barrios-Blandino A; Del Río B; Vivancos J
Mult Scler Relat Disord; 2020 Sep; 44():102250. PubMed ID: 32531754
[TBL] [Abstract][Full Text] [Related]
10. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; de Vos M; Richert ND; Uitdehaag BM; Barkhof F; Killestein J;
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):879-84. PubMed ID: 26369555
[TBL] [Abstract][Full Text] [Related]
11. Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Fragoso YD; Gama PDD; Gomes S; Khouri JMN; Matta APDC; Fernanda Mendes M; Stella CRAV
Mult Scler Relat Disord; 2016 Mar; 6():64-65. PubMed ID: 27063625
[TBL] [Abstract][Full Text] [Related]
12. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
[TBL] [Abstract][Full Text] [Related]
13. Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report.
Sepúlveda M; Llufriu S; Blanco Y; Solà-Valls N; La Puma D; Berenguer J; Villoslada P; Saiz A
J Neurol; 2015 Jan; 262(1):219-21. PubMed ID: 25408366
[No Abstract] [Full Text] [Related]
14. Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Pitarokoili K; Hellwig K; Lukas C; Gold R
Mult Scler; 2017 Mar; 23(3):483-486. PubMed ID: 28260421
[TBL] [Abstract][Full Text] [Related]
15. Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.
Dalla Costa G; Martinelli V; Moiola L; Sangalli F; Colombo B; Finardi A; Cinque P; Kolb EM; Haghikia A; Gold R; Furlan R; Comi G
Ann Neurol; 2019 Apr; 85(4):606-610. PubMed ID: 30761586
[TBL] [Abstract][Full Text] [Related]
16. Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.
Iaffaldano P; Viterbo RG; Trojano M
J Neurol; 2016 Aug; 263(8):1620-5. PubMed ID: 27260295
[TBL] [Abstract][Full Text] [Related]
17. Acute retinal necrosis and immune reconstitution inflammatory syndrome in a natalizumab-treated patient with multiple sclerosis.
Saraiva VS
Retin Cases Brief Rep; 2015; 9(3):195-7. PubMed ID: 25933353
[TBL] [Abstract][Full Text] [Related]
18. [Regarding the article: "Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].
de Sá J
Acta Med Port; 2014; 27(4):409-10. PubMed ID: 25203944
[No Abstract] [Full Text] [Related]
19. Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Holmøy T; Beiske AG; Zarnovicky S; Myro AZ; Røsjø E; Kerty E
BMC Neurol; 2016 Oct; 16(1):197. PubMed ID: 27756254
[TBL] [Abstract][Full Text] [Related]
20. Body weight-based natalizumab treatment in adult patients with multiple sclerosis.
Tanaka M; Kinoshita M; Foley JF; Tanaka K; Kira J; Carroll WM
J Neurol; 2015 Mar; 262(3):781-2. PubMed ID: 25663410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
